#emraclidine

Live, measured metrics for the hashtag #emraclidine from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #emraclidine

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$10.85/ year · 11-character #name
Claim #emraclidine$10.85/yrBuy on hashtag.space (web3)
card via hashtag.org · tokens via hashtag.space
0
Uses / 7 days
Mastodon
0
Accounts / 7 days
Mastodon
1
Recent posts
Mastodon
Recent pace
Mastodon · last 1
0
Avg reactions / post
Mastodon · last 1
Reddit posts / month
Reddit search
Open-web mentions
hashtag.org Firehose

Day-by-day usage

measured · fosstodon.org (Mastodon public tags API) · fetched 2026-08-12 05:40 UTC
0
08-06
0
08-07
0
08-08
0
08-09
0
08-10
0
08-11
0
08-12

0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · fosstodon.org (Mastodon public search API) · fetched 2026-08-12 05:40 UTC

No related tags with measured usage found for #emraclidine.

Live pulse

measured · fosstodon.org (Mastodon tag timeline) · fetched 2026-08-12 05:40 UTC

Everything below is measured over the latest 1 public posts.

Posting hours (UTC)

00:0012:0023:00

Languages: English (1)

Avg boosts / post: 1

Top of the latest posts

  • Yale School of Medicine's Chair of Psychiatry, John Krystal, MD, investigated a new #schizophrenia drug. In The Lancet last week, researchers say #Emraclidine showed significant #antipsychotic effect, and could be an important treatment opt

    Yale School of Medicine@[email protected]012022-12-19 15:39 UTCView post →

What “emraclidine” means

Wikipedia

Emraclidine is an investigational antipsychotic for the treatment of both schizophrenia and Alzheimer's disease psychosis developed by Cerevel Therapeutics. On November 11, 2024, AbbVie announced that phase 2 clinical trials did not show an improvement in Positive and Negative Syndrome Scale (PANSS) total scores from baseline when compared to the placebo group.

Emraclidine” on Wikipedia (CC BY-SA) →

#emraclidine across platforms

every network with a public tag surface

Follow #emraclidine straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/emraclidine